Front | Back |
How can drugs be cliassified ?
|
-Clinical Indication: antifungal, antispasmodics
-Mechanism of action: diuretics, beta-blocker, antihypertensives -Body system: respiratory drugs, cardiovascular drugs, integumentary system drugs |
Antidysrhythmics groups
|
Group I: fast sodium channel inhibitors, Group II: beta-adrenergic blockers, Group III: prolong cardiac repolarization, and Group IV: calcium channel blockers
|
Cardiac glycosides (digoxin) pharm action
|
Positive inotropic effect - increases contraction strength
|
ACE-inhibitors (catopril
Angiotensin receptor blockers (losartan) Diuretics (furosemide, spironolactone) PHARM ACTION |
Reduce fluid retension, which decreases overstretch of myocardial muscle durring ventricular filling (reduced preload
|
ACE-Inhibitors (catopril)
Angiotensin receptor blockers (losartan) Vasodilators (nitrates, hydralazine) Aldosterone antagonist (spironlactone PHARM ACTION |
Reduce systemic BP, which improves efficiency of ventricle to expel blood (reduced afterload
|
Low-dose Beta-adrenergic blockers (carvedilol
PHARM ACTION |
Blunt long-term sympathetic stimulation associated with worsening heart failure
|
B-type natriuretic peptide (nesiritide) PHARM ACTION
|
Augment neurohormonal response to heart failure with vasodilation; reduce fluid retention
|
Antidysrhythmic drugs
Ca-channel blockers Beta-adrenergic blockers PHARM ACTION |
Converts to normal sinus rhythm, abolishes dysrhythmia, or controls rate
|
Nitrates
Ca-channel blockers (dilatiazem) Beta-adrenergic blockers (propranolol) PHARM ACTION |
Coronary vasodilation and/or lessens work of the heart
|
Antiplatelets (aspirin)
Anticoagulants (warfarin) Fibrinolytics (alteplase) PHARM ACTION |
Prevent or treat clot formation in coronary arteries
|
Antihyperlipidemics (lovastatin)
PHARM ACTION |
Prevent atherosclerosis and risk for clot formation in coronary arteries
|
Drugs that effect Cardiac Output
|
Beta blockers, diuretics, CCBs
|
Drugs that effect Total Peripheral Resistance
|
ACE inhibitors, ARBs, Alpha blockers, Alpha-2-agonists, CCBs, diuretics, sympatholytics, vasodilators
|
Diuretics promote
|
the formation & excretion of urine, resulting in a loss of excess salt and water from the body by renal excretion
|
3 types used to treat HTN
|
Thiazide, loop diuretics, and potassium sparing diuretics. Thiazides are recommended as 1st-line drug therapy (for uncomplicated HTN).
|